echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Amino Acids Research > Evonik Q3 Results: Sales up 4%, up 31% on profit

    Evonik Q3 Results: Sales up 4%, up 31% on profit

    • Last Update: 2020-06-29
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    1, sales rose 4% to 3.4 billion eurostfH
    2Adjusted EBITDA increased significantly year-on-year to 653 million euros (up 31%), maintaining the high growth momentum of the previous quartertfH
    3, the three major business sectors have achieved year-on-year revenue growthtfH
    4Adjusted EBITDA margin reached a high level of 19.4%tfH
    Overall, sales and profits continued the strong growth momentum in the first and second quarters of this yearGlobal demand for Evonik products remains at a good leveltfH
      Key data for the third quarter of 2015 and the first nine months of 2015 tfH sales rose 4 per cent to EUR 3,365 million in the third quarter due to higher prices and positive exchange rate effects, while sales rose 6 per cent to EUR 10,309 million in the first nine months, supported by higher sales tfH
      In the third quarter, the Group's adjusted EBITDA climbed 31% to 653 million euros, maintaining the high level of previous quarters Adjusted EBITDA increased 37% to EUR 1,964 million in the first nine months tfH
      This was mainly due to rising sales, new plant production and higher prices Other positive factors include a small decline in raw material costs and exchange rate impacts tfH
      Adjusted EBITDA margin was particularly strong in the third quarter, at 19.4% Adjusted EBITDA margin rose to 19.1% in the first nine months from 14.8% a year earlier Adjusted net income rose 36 percent to 296 million euros in the third quarter, and rose 56 percent to 923 million euros in the first nine months tfH
      Business segment performance tfH in the third quarter, all three business segments achieved year-on-year growth in revenue, the first in FY2015 tfH
      Sales in the nutrition and consumer chemicals segment rose 22 percent to 1.24 billion euros in the third quarter Adjusted EBITDA jumped 85% to 382 million euros Adjusted EBITDA margin jumped to 30.8% from 20.3% in the previous year tfH
      Third-quarter sales in the Resource Efficiency segment rose 2 percent to 1.044 billion euros Adjusted EBITDA edged up to EUR 216 million Adjusted EBITDA margin was essentially unchanged from the previous year, at 20.7% tfH
      The functional materials segment reported third-quarter sales of 858 million euros, down 11% Adjusted EBITDA rose 4 percent to 94 million euros Adjusted EBITDA margin was 11%, up from 9.3% in the same period in 2014 tfH
      Recognizing its full-year forecast tfH , Whichon confirmed its full-year results in light of continued strong results tfH
      Due to the strong performance of the business, the company raised its forecast sales to 13.5 billion euros (2014: 12.9 billion euros) and adjusted EBITDA to 2.4 billion euros (2014: 1.9 billion euros) tfH
      1, sales increased 4% to 3.4 billion euros tfH
      2 Adjusted EBITDA increased significantly year-on-year to 653 million euros (up 31%), maintaining the high growth momentum of the previous quarter tfH
      3, the three major business sectors have achieved year-on-year revenue growth tfH
      4 Adjusted EBITDA margin reached a high level of 19.4% tfH
      Overall, sales and profits continued the strong growth momentum in the first and second quarters of this year Global demand for Evonik products remains at a good level tfH
      Key data for the third quarter of 2015 and the first nine months of 2015 tfH sales rose 4 per cent to EUR 3,365 million in the third quarter due to higher prices and positive exchange rate effects, while sales rose 6 per cent to EUR 10,309 million in the first nine months, supported by higher sales tfH
      In the third quarter, the Group's adjusted EBITDA climbed 31% to 653 million euros, maintaining the high level of previous quarters Adjusted EBITDA increased 37% to EUR 1,964 million in the first nine months tfH
      This was mainly due to rising sales, new plant production and higher prices Other positive factors include a small decline in raw material costs and exchange rate impacts tfH
      Adjusted EBITDA margin was particularly strong in the third quarter, at 19.4% Adjusted EBITDA margin rose to 19.1% in the first nine months from 14.8% a year earlier Adjusted net income rose 36 percent to 296 million euros in the third quarter, and rose 56 percent to 923 million euros in the first nine months tfH
      Business segment performance tfH in the third quarter, all three business segments achieved year-on-year growth in revenue, the first in FY2015 tfH
      Sales in the nutrition and consumer chemicals segment rose 22 percent to 1.24 billion euros in the third quarter Adjusted EBITDA jumped 85% to 382 million euros Adjusted EBITDA margin jumped to 30.8% from 20.3% in the previous year tfH
      Third-quarter sales in the Resource Efficiency segment rose 2 percent to 1.044 billion euros Adjusted EBITDA edged up to EUR 216 million Adjusted EBITDA margin was essentially unchanged from the previous year, at 20.7% tfH
      The functional materials segment reported third-quarter sales of 858 million euros, down 11% Adjusted EBITDA rose 4 percent to 94 million euros Adjusted EBITDA margin was 11%, up from 9.3% in the same period in 2014 tfH
      Recognizing its full-year forecast tfH , Whichon confirmed its full-year results in light of continued strong results tfH
      Due to the strong performance of the business, the company raised its forecast sales to 13.5 billion euros (2014: 12.9 billion euros) and adjusted EBITDA to 2.4 billion euros (2014: 1.9 billion euros) tfH
    Share it on feed
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.